Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-09-11

Clinical Trial Update: A Cohort Study of Incretin-based Therapy Combined With Insulin in Type 2 Diabetic Patients for 5 Years [NA]

View source ↗

Summary

This document reports a 5-year cohort study evaluating incretin-based therapy combined with insulin in patients with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Incretin-based therapy

Snippet

Sponsor: Nagaoka Red Cross Hospital | Conditions: Type 2 Diabetes Mellitus | NA | Status: UNKNOWN